3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
4
Completed
3
Withdrawn
2
Recruiting
2
Unknown
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Head & Neck
2
Genitourinary
2
Gastrointestinal
2
Thoracic
1
CNS
1
Breast
1
Conditions
Prostatic Neoplasms
31
Squamous Cell Carcinoma of Head and Neck
21
Carcinoma, Non-Small-Cell Lung
20
Neoplasms
18
Breast Neoplasms
18
Glioblastoma
17
Esophageal Squamous Cell Carcinoma
16
Rectal Neoplasms
15
Lung Neoplasms
15
Esophageal Neoplasms
15
Head and Neck Neoplasms
12
Uterine Cervical Neoplasms
11
Neoplasm Metastasis
10
Glioma
10
Nasopharyngeal Carcinoma
8
Stomach Neoplasms
7
Radiation Injuries
7
Oropharyngeal Neoplasms
7
Brain Neoplasms
7
Hyperthermia
6
Carcinoma, Hepatocellular
6
Astrocytoma
6
Urinary Bladder Neoplasms
5
Small Cell Lung Carcinoma
5
Sarcoma
5
Oligodendroglioma
5
Colorectal Neoplasms
5
Carcinoma, Renal Cell
5
Triple Negative Breast Neoplasms
4
Pancreatic Neoplasms
4
Interventions
Bevacizumab
9
pembrolizumab
5
lenvatinib
5
durvalumab
5
atezolizumab
5
tremelimumab
3
fludarabine
3
camrelizumab
3
apatinib
3
Ipilimumab
3
Cyclophosphamide
3
regorafenib
2
Riluzole
2
Radiotherapy
2
Nivolumab
2
Magnetic Resonance Imaging
2
Idarubicin
2
Blood Specimen Collection
2
Biopsy
2
yttrium chloride
1
trastuzumab deruxtecan
1
spartalizumab
1
sintilimab
1
pertuzumab
1
ferric carboxymaltose
1
epigallocatechin gallate
1
donafenib
1
cemiplimab
1
brodalumab
1
Yttrium-90
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Liver Neoplasms
×
Radiotherapy
×
Clear all
NCT04075305
2026-03-05
MOMENTUM
UMC Utrecht
Recruiting
8,000 enrolled
NCT04545957
2025-07-28
JUMP
Brigham and Women's Hospital
Phase NA
Recruiting
86 enrolled